Adamis Pharmaceuticals Corp (ADMP): Ruff, were you able to average down any...

Featured News Placeholder

Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the Internation...

NASDAQ:TLSA

Stock Options

NEW to INVESTORSHUB

Adamis Pharmaceuticals Corp (ADMP)

Reply Private New

Replies (1) Next 10 Prev Next

Send PM

Followers	28
Posts	1014
Boards Moderated	0
Alias Born	03/10/2014

FREE
ADMP REPORT

Re: Ruffieruff post# 1609

Monday, 02/26/2018 8:40:22 AM

Monday, February 26, 2018 8:40:22 AM

Ruff, were you able to average down any during the dip? I was able to get my avg down to 4.06
Guess my order filled when someone's stop loss triggered?
Hoping for that partner announcement in the coming weeks to get this thing back to $6 or more!
I've put in way more than I wanted here, but feel pretty bullish after the announcement that they are down to final negotiations between two partners.
Best of luck my friend!
IMHO

In My Own Personal Opinion Of Course!

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ADMP News

Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 03/17/2023 12:09:24 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 03/17/2023 12:07:50 PM
Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/16/2023 08:24:01 PM
Annual Report (10-k) • Edgar (US Regulatory) • 03/16/2023 07:59:02 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 03/14/2023 09:26:36 PM
Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate Update • GlobeNewswire Inc. • 03/14/2023 08:01:00 PM
Adamis Pharmaceuticals Announces $3.0 Million Registered Direct Offering • GlobeNewswire Inc. • 03/14/2023 12:30:00 PM
Adamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of Merger • GlobeNewswire Inc. • 02/27/2023 09:05:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 02/23/2023 12:09:13 PM
Nasdaq Grants Adamis Pharmaceuticals’ Request for Extension to Comply with Continued Listing Requirements • GlobeNewswire Inc. • 02/22/2023 09:01:00 PM
Quarterly Report (10-q) • Edgar (US Regulatory) • 11/14/2022 09:59:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 11/14/2022 09:48:05 PM
Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/14/2022 09:10:07 PM
Adamis Pharmaceuticals Schedules Third Quarter 2022 Financial Results Conference Call and Corporate Update • GlobeNewswire Inc. • 11/07/2022 09:05:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 10/04/2022 10:16:15 AM
Current Report Filing (8-k) • Edgar (US Regulatory) • 10/04/2022 10:09:16 AM
Adamis Announces Review of Strategic Alternatives • GlobeNewswire Inc. • 10/03/2022 08:30:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 09/23/2022 09:08:52 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 09/23/2022 09:06:45 PM
Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects • GlobeNewswire Inc. • 09/21/2022 11:30:00 AM
Notice of Effectiveness (effect) • Edgar (US Regulatory) • 09/20/2022 10:03:49 AM
Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk Subjects • GlobeNewswire Inc. • 09/12/2022 08:05:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 09/12/2022 10:05:18 AM
Securities Registration Statement (simplified Form) (s-3) • Edgar (US Regulatory) • 09/09/2022 09:13:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 08/18/2022 07:09:02 PM

More ADMP News

InvestorsHub NewsWire

FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM

ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM

Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM

ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM

Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM

OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM

Start posting your company's news

Only $200 per official company press release!